UK regulators OK two Oxford Biomedica sites for cell therapy processing
The MHRA has granted Oxford Biomedica permission to develop and manufacture cell therapies at two more sites in the UK.
Archives for July 31, 2016
West: Amgen mAb approval helps validate drug delivery tech
Regulatory approvals are driving interest in West's Smartdose and Crystal Zenith delivery technologies, the firm says ahead of the launch of a monthly-dose version of Amgen's Repatha.